ReViral
ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
ReViral operates in biotechnology, health care, medical, therapeutics based in Europe, Middle East, and Africa (EMEA), founded in 2011.
As a business in biotechnology, health care, medical, therapeutics, ReViral is listed here with the public details available about it.
Europe, Middle East, and Africa (EMEA) is where the company is located.
The company is listed at the Series_C stage of development.
Its team size is recorded as c_00011_00050 employees.
Public records show total funding of about $121M.
| Sector | Biotechnology, Health Care, Medical, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2011 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $121,000,000 |
Website: www.reviral.co.uk
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account